Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by Noteable

T.ONC

RE:RE:Pelareorep in 3rd line HR+/HER2 negative breast cancer

An ASCO Meeting Abstract from the 2022 ASCO Annual Meeting has cited that...

September 18, 2024

T.ONC

RE:RE:RE:How does Accelerated Approval work

“The accelerated approval program may lower the operational hurdles for...

September 18, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:ONCY's Bracelet-1 was in HR+/HER2 negative breast cancer

 "BRACELET-1 substantially de-risks our HR+/HER2- breast cancer...

September 18, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:ONCY's Bracelet-1 was in HR+/HER2 negative breast cancer

Reposts are necessary for the "goofballs" that you have referenced.

September 18, 2024

T.ONC

RE:Pelareorep in 3rd line HR+/HER2 negative breast cancer

Post by Noteable on Sep 15, 2024 4:43pm Pelareorep in 3rd line HR...

September 18, 2024

T.ONC

RE:RE:How does Accelerated Approval work

This is for the benefit of Quentin30 - who doesn't own any ONCY stock BTW...

September 18, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:ONCY's Bracelet-1 was in HR+/HER2 negative breast cancer

Furthermore Accelerated Approvals are becoming more frequently granted by the...

September 18, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:ONCY's Bracelet-1 was in HR+/HER2 negative breast cancer

Quentin30 while IND-213 as a study wasn't powered for statistical...

September 18, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:ONCY's Bracelet-1 was in HR+/HER2 negative breast cancer

You don't seem to understand much. ONCY's 180-200 patient ...

September 18, 2024

T.ONC

RE:RE:RE:RE:RE:RE:ONCY's Bracelet-1 was in HR+/HER2 negative breast cancer

Once again the major determinant of clinical benefit for the FDA is overall...

September 18, 2024

T.ONC

RE:RE:RE:RE:RE:ONCY's Bracelet-1 was in HR+/HER2 negative breast cancer

ONCY has demonstrated that PFS was 38.2% better in the pelareorep...

September 18, 2024

T.ONC

RE:RE:RE:RE:RE:Quentin30 is a pathological prevaricator.

Quentin30 Koffey what are you blathering about again?  Brad Thompson...

September 17, 2024

T.ONC

RE:RE:RE:RE:RE:Quentin30 is a pathological prevaricator.

Yes ONCY has affirmed their pursuit of an Accelerated Approval pathway after...

September 17, 2024

T.ONC

RE:RE:RE:RE:ONCY's Bracelet-1 was in HR+/HER2 negative breast cancer

Quentin30 Koffey doesnt appear to read what had been posted  so here is...

September 17, 2024

T.ONC

RE:RE:RE:RE:Quentin30 is a pathological prevaricator.

In contrast to you Quentin30 Koffey I've supported my posts with relative...

September 17, 2024

T.ONC

RE:RE:RE:Quentin30 is a pathological prevaricator.

No Quentin30 Koffey. ONCY will be running an adaptive Phase 2b -> Phase 3 ...

September 17, 2024

T.ONC

RE:RE:RE:RE:RE:RE:How does Accelerated Approval work

" Breakthrough therapy designation (BTD) is granted for drugs...

September 17, 2024

T.ONC

RE:RE:RE:RE:RE:How does Accelerated Approval work

" Accelerated approval (AA) targets candidates that are...

September 17, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Pelareorep in 3rd line HR+/HER2 negative breast cancer

https://stockhouse.com/companies/bullboard?symbol=oncy&postid=36227894

September 17, 2024

T.ONC

RE:RE:RE:RE:How does Accelerated Approval work

The FDA instituted its Accelerated Approval Program to allow for...

September 17, 2024

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

Revive Therapeutics Ltd

Revive Therapeutics Ltd C.RVV

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of ... view more »